Cancer diagnostics company aims to make genomic testing less invasive and more accessible for patients
LOS ANGELES, November 10, 2014 – Cynvenio Biosystems, Inc. announced today that it was awarded a 2014 ABBY Award by the Adaptive Business Leaders Organization (ABL) during its 15th annual Innovations in HealthcareSM Leadership Event, held October 28 in San Francisco. The ABBY award recognizes innovative organizations and individuals who are dramatically reducing the cost of quality healthcare through their medical or information technologies, or innovative approaches to the delivery of healthcare.
“Both of Cynvenio’s competitors for the ABBY Award in the ‘Innovative Medical Devices/Diagnostic’ category have very impressive products. Yet, the voters in the audience obviously recognized that Cynvenio’s LiquidBiopsy® technology will be game-changing for patients who will no longer need to have painful biopsies to precisely define their type and stage of cancer, enabling providers to match patients with the most effective therapy,” said Mimi Grant, president, Adaptive Business Leaders. “The Adaptive Business Leaders Organization first launched Innovations in HealthcareSM 15 years ago to identify and acknowledge organizations like Cynvenio that are truly reducing the cost of quality care; we are very proud to recognize André de Fusco, Cynvenio’s CEO, and their entire team for bringing this outstanding innovation to the medical world.”
Nine finalists selected by an ABL committee across three categories – “Innovative Medical Devices/Diagnostic,” Innovative Approach to the Delivery of Healthcare” and “Innovative eHealth Solutions” – made presentations at the event. Secret ballot voting by all event attendees followed.
“We’re honored to receive the 15th ABBY Award for Innovations in HealthCare and to be in the company of Dr. Thomas Fogarty, a disruptive innovator who gave the world the embolectomy catheter. The Cynvenio team has worked tirelessly over the last few years to make our LiquidBiopsy® rare cell sequencing technology available to doctors and cancer research centers in the interest of better patient outcomes,” said André de Fusco, CEO of Cynvenio.
About Cynvenio Biosystems, Inc.
Cynvenio is a molecular information technology company focused on individualizing cancer treatment by providing longitudinal insights into each patient via the genomic analysis of their cancer from a standard blood draw.Cynvenio’s LiquidBiopsy® and ClearID™ clinical assays for solid tumors are used as therapy finders to periodically assess patients’ individual mutations and match them with targeted cancer therapies and clinical trials. Both blood tests can be used to complement traditional tissue biopsy analysis, or as standalone tests to find therapies for patients in which tissue biopsy is deemed difficult or too risky to harvest.Cynvenio is headquartered in Westlake Village, California (Los Angeles). For more information, visit http://www.cynvenio.com.
LiquidBiopsy® is a registered trademark of Cynvenio Biosystems, Inc.
About the Adaptive Business Leaders (ABL) Organization
For over 25 years, the Adaptive Business Leaders Organization (ABL) has helped its Members grow great companies through its Healthcare and Technology CEO Round Tables. Each month, Members leverage each other’s skills, expertise, and connections, in a confidential, personal advisory board setting. During each session, Members share with their non-competitive peers, their best practices as they tackle topics like: “Resilient Management: How Healthcare Organizations Can Remain Positive in the Face of Challenge & Change,” “Creating a Culture of Accountability,” and “Lessons Learned in Accountable Care.” Also, each session has a Featured Member or Guest Speaker who makes a Strategic Advisory Board presentation, imparting valuable insights and receiving leveraged feedback in return from the Group.
ABL Members are also encouraged to attend frequent ABL Workshops and Conferences. The largest of these is the Innovations in HealthcareSM ABBY Awards Event. Other events include the annual “Top Tech Trends,” “Envisioning the Future of Healthcare,” "Shaping Effective Boards of Directors,” and “Today’s Faster Ways to Grow Your Market.” In addition to the Members’ peer mentors, each Round Table’s professional facilitator serves as an objective business advisor, offering executive and industry insights.
ABL’s Healthcare Round Tables are held in Los Angeles, Orange County, San Diego, Silicon Valley, San Francisco, and Oakland. And the Organization’s Technology Round Tables are held throughout Los Angeles and Orange Counties. More information about and testimonials from ABL Members can be found here: http://www.abl.org.